ABSTRACT Objective: to determine the ED90 (minimum effective dose in 90% of patients) of sugammadex for the reversal of rocuronium-induced moderate neuromuscular blockade (NMB) in patients with grade
These are peer-reviewed supplementary materials for the article 'Real-world comparison between weekly versus biweekly dosing of cetuximab for metastatic colorectal cancer' published in the Journal of